Entity Details

Primary name TPK1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9H3S4
EntryNameTPK1_HUMAN
FullNameThiamin pyrophosphokinase 1
TaxID9606
Evidenceevidence at protein level
Length243
SequenceStatuscomplete
DateCreated2004-03-01
DateModified2021-06-02

Ontological Relatives

GenesTPK1

GO terms

Show/Hide Table
GOName
GO:0004788 thiamine diphosphokinase activity
GO:0005524 ATP binding
GO:0005829 cytosol
GO:0006772 thiamine metabolic process
GO:0009229 thiamine diphosphate biosynthetic process
GO:0016301 kinase activity
GO:0030975 thiamine binding
GO:0042723 thiamine-containing compound metabolic process
GO:0042802 identical protein binding

Subcellular Location

Show/Hide Table

Domains

Show/Hide Table
DomainNameCategoryType
IPR006282 Thiamin pyrophosphokinaseFamilyFamily
IPR007371 Thiamin pyrophosphokinase, catalytic domainDomainDomain
IPR007373 Thiamin pyrophosphokinase, thiamin-binding domainDomainDomain
IPR016966 Thiamin pyrophosphokinase, eukaryoticFamilyFamily
IPR036371 Thiamin pyrophosphokinase, thiamin-binding domain superfamilyFamilyHomologous superfamily
IPR036759 Thiamin pyrophosphokinase, catalytic domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
614458 OMIMThiamine metabolism dysfunction syndrome 5, episodic encephalopathy type (THMD5)An autosomal recessive metabolic disorder due to an inborn error of thiamine metabolism. The phenotype is highly variable, but in general, affected individuals have onset in early childhood of acute encephalopathic episodes associated with increased serum and CSF lactate. These episodes result in progressive neurologic dysfunction manifest as gait disturbances, ataxia, dystonia, and spasticity, which in some cases may result in loss of ability to walk. Cognitive function is usually preserved, although mildly delayed development has been reported. These episodes are usually associated with infection and metabolic decompensation. Some patients may have recovery of some neurologic deficits. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00152 ThiamineDrugbanksmall molecule
DB04768 Pyrithiamine PyrophosphateDrugbanksmall molecule

Interactions

3 interactions